MedDataX Logo

Sleep Disorders in Patients With Multiple Sclerosis

NCT ID: NCT00137904

Last Updated: 2006-02-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

51 participants

Study Classification

OBSERVATIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fatigue is a frequent and disabling symptom in patients with multiple sclerosis (MS). The pathophysiology of this sign is not fully understood. Some data suggest that the fatigue is associated with sleep disorders. The aim of this study is to determine the polysomnographic parameters in MS patients with fatigue in comparison to MS patients without fatigue.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with multiple sclerosis
* Expanded Disability Status Scale score \< or = 5
* Fatigue (Modified Fatigue Impact Scale \> 45), with a disease duration \> 3 months

Exclusion Criteria

* Depression
* Cognitive disorders
* EDSS \> 5
* Epilepsia
* Obesity
* Drug inducing sleep disorders
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

Sponsor Role collaborator

Groupe Hospitalier Pitie-Salpetriere

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bruno Stankoff, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

CIC-Pitié-Salpêtrière

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre d'Investigation Clinique-Hopital Pitié-Salpêtrière

Paris, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bruno Stankoff, MD, PhD

Role: CONTACT

[email protected]
33-142161950

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marie-Laure Welter, MD

Role: primary

[email protected]
33-42161950

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RBM0242

Identifier Type: -

Identifier Source: org_study_id